“As patients and care teams evolve the standard of care to the home, common barriers emerge around complexity with access, usability, security, and supply chain.”

— Erica Spatz, MD, MS, Associate Professor, Section of Cardiovascular Medicine, Yale Center for Outcomes Research and Evaluation, Yale School of Medicine

“Koneksa’s work, aimed at bringing new treatments for patients with PD, is fully aligned with the V3+ framework.”

— Jennie Lavine, PhD, Sr. Applied Data Scientist, Koneksa Health

— Kelly Scherer, MPH, Sr. Product Manager, Koneksa Health

— Elena Izmailova, PhD, CSO, Koneksa Health

“LVAD patients require close monitoring in the outpatient setting and home monitoring plays a crucial part of their outpatient management. The use of Stel Bluetooth transmissions gives us the confidence that we can report more accurate results in a timely manner to their care team.”
— Terea Williamson
Director of Diagnostics/VP of Operations, Orthodynamics Company, Inc.

“The V3+ framework highlights the need for early and iterative involvement of end-users and stakeholders to align user requirements and technical specifications.”

— Marian Schoone Consultant, TNO Healthy Living

“The V3+ framework will enable better patient-centered research in pediatrics and pediatric cardiology by creating a structure for the evaluation of sensor-based digital health technologies. This is a vital need in the field, given how new this all is for children!”
— Animesh (Aashoo) Tandon, MD, MS, Director of Cardiovascular Innovation, Cleveland Clinic Children’s

“Long-term, continuous data collection puts usability front and center. We debated each and every detail, such as size and weight of the watch, the shape of the PPG lens, the watch band materials, and so on, to deliver this unique DHT product with high usability and technical excellence.” — Christine Guo, Chief Scientific Officer, ActiGraph

“Using DiMe’s V3+ framework, we were able to implement a fast-track process at UCB to make data-driven decisions on selecting fit-for-purpose DHTs for our clinical trials.”

— Ute Conradi, Head of Medical Device Innovation, UCB Pharma

“I see the profound impact of our work in using wearables for pediatric cancer survivors. It underscores the need for robust guidelines and frameworks in human-centered design, ensuring that technology not only advances scientific research but also genuinely serves the needs and improves the lives of children and families.”
— Emre Sezgin, PhD, Principal Investigator, Intelligent Futures Research Lab at NCH

“Usability of digital adherence solutions is the key to success in achieving comprehensive patient data on drug exposure.” — Oana Paun, Quality Assurance Manager, AARDEX Group